$BLLN

Tsao David sold $2.0M of BLLN

Tsao David (Chief Technology Officer) sold 20,000 shares of BillionToOne, Inc. (BLLN) at an average of $102.27 ($98.74–$104.47, $2.05M total) across 11 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tsao David
Published Jun 17, 2026, 9:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
medium confidence
Mentioned
$BLLN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The newest disclosed fact is the CTO’s open-market sale totaling ~$2.05M across 11 trades, executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 designation suggests limited incremental information content.

03

What to watch

The filing shows remaining holdings (1,000 shares after sale) and a multi-tranche execution window; traders may overreact to the headline dollar amount without considering the plan’s mechanics.

Relevance 5/10Novelty 6/10Timing: Filed June 17; transactions executed June 15.

Background

This is an SEC Form 4 insider transaction disclosure for BillionToOne, Inc. (BLLN).

Company-level read

Ticker impact

$BLLNNeutralMedium confidence
Context

BillionToOne CTO Tsao David sold about $2.05M of BLLN shares in an open-market sale under a pre-arranged 10b5-1 plan on June 15.

Expected impact

Likely limited near-term impact; any reaction should be small unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing is a primary-source Form 4 showing a sizable sale, yet it explicitly references a pre-arranged 10b5-1 plan, which typically dampens inference about new information.

Market effects

No clear sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale was executed under a pre-arranged 10b5-1 plan, it may reflect routine liquidity/compensation rather than a change in fundamentals.

Key entities

  • BillionToOne, Inc.

    Subject of the insider transaction disclosure; CTO sold shares totaling ~$2.05M under a 10b5-1 plan.

  • Tsao David

    Chief Technology Officer; reported open-market sale of BLLN shares.

Related articles

$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.